Condition: Vulvar Cancer · Sentinel Lymph Node · Lymph Node Metastases · Sponsor: University Medical Center Groningen
Vulvar cancer patients with SN-metastasis \> 2mm will receive chemoradiation instead of an inguinofemoral lymphadenectomy.
This description comes directly from the study's public registry record.
Maaike H Oonk, MD PhD · +31-50-3613000 · m.h.m.oonk@umcg.nl
Liza Lahaye · eventinbox@umcg.nl
Always discuss trial participation with your own doctor first.
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange, California, United States | Recruiting |
| Mount Sinai Medical Center | Miami Beach, Florida, United States | Recruiting |
| Baystate Medical Center | Springfield, Massachusetts, United States | Recruiting |
| Spectrum Health at Butterworth Campus | Grand Rapids, Michigan, United States | Recruiting |
| Munson Medical Center | Traverse City, Michigan, United States | Recruiting |
| Nebraska Methodist Hospital | Omaha, Nebraska, United States | Recruiting |
| Women's Cancer Center of Nevada | Las Vegas, Nevada, United States | Recruiting |
| Memorial Sloan Kettering Basking Ridge | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Commack | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester | Harrison, New York, United States | Recruiting |
+ 15 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05076942